, Tracking Stock Market Picks
Enter Symbol:
Incyte Corporation (INCY) [hlAlert]

up 962.03 %

Incyte Corporation (INCY) rated Outperform with price target $129 by Oppenheimer

Posted on: Monday,  Nov 9, 2015  9:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Incyte Corporation (NASDAQ: INCY) on 11/09/2015. Previously Oppenheimer rated Outperform Incyte Corporation (NASDAQ: INCY) on 02/26/2010., when
the stock price was $10.72. Since then, Incyte Corporation has gained 962.03% as of 01/14/2016's recent price of $113.85.
If you would have followed the previous Oppenheimer's recommendation on INCY, you would have gained 962.03% of your investment in 2148 days.

Incyte Corporation (Incyte) is a drug discovery and development company focused on developing small molecule drugs to treat serious unmet medical needs. The Company has a pipeline with programs in oncology, inflammation and diabetes. Incyte?s pipeline includes compounds in various stages of development in the areas of oncology, inflammation, diabetes and human immunodeficiency virus (HIV).

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/9/2015 9:25 AM Buy
104.04 129.00
as of 8/27/2015
1 Week up  11.61 %
1 Month up  4.15 %
3 Months up  6.62 %
1 YTD up  124.86 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/11/2013 8:25 AM Buy
37.64 43.00
8/2/2013 8:25 AM Buy
26.10 28.00
5/19/2011 8:25 AM Buy
19.86 25.00
10/1/2010 8:25 AM Buy
16.02 22.00
2/26/2010 8:25 AM Buy
10.72 15.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy